INDmoney
Teva Pharmaceutical Industries Ltd Stock Performance
as on January 28, 2026 at 9:39 pm IST
Day's Low
Day's High
$30.98$32.83
5.23%
Downside
0.43%
Upside
52 Week's Low
52 Week's High
$12.47$33.4261.87%
Downside
2.23%
Upside
Teva Pharmaceutical Industries Ltd share price movements today
- Previous Close
- $32.53
- Open
- $31.39
- Volume
- 7.1M
- Day's Low - High
- $30.98 - $32.83
- 52 Week Low - High
- $12.47 - $33.42
Teva Pharmaceutical Industries Ltd Historical Returns
- 1 Month Return
- + 2.01 %
- 3 Month Return
- + 64.46 %
- 1 Year Return
- + 51.09 %
- 3 Year Return
- + 213.39 %
- 5 Year Return
- + 165.55 %
Teva Pharmaceutical Industries Ltd Stock Fundamentals & Key Indicators
Check Teva Pharmaceutical Industries Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$36.9B
EPS (TTM)
2.6283
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.40%
PE Ratio (TTM)
52.69
Industry PE ratio
17.274050632911393
PEG Ratio
1.2934
EBITDA
4.6B
Revenue (TTM)
16.8B
Profit Margin
4.25%
Return On Equity TTM
9.71%
Teva Pharmaceutical Industries Ltd Stock Valuation
Track how Teva Pharmaceutical Industries Ltd P/E has moved over time to understand its valuation trends.
Teva Pharmaceutical Industries Ltd in the last 5 years
Lowest (3.34x)
March 31, 2022
Industry (17.27x)
January 28, 2026
Today (52.69x)
January 28, 2026
Highest (12.90x)
December 31, 2024
Today’s Price to Earnings Ratio: 52.69x
Teva Pharmaceutical Industries Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Teva Pharmaceutical Industries Ltd with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| $36.9B | 165.55% | 52.69 | 4.25% | ||
| NA | $14.4B | NA | NA | 0.00% | |
| BUY | $21.6B | NA | 18.08 | 40.65% | |
| BUY | $46.2B | NA | 22.54 | 13.81% | |
| HOLD | $15.2B | -23.68% | -21.95 | -26.13% |
Stock Returns calculator for Teva Pharmaceutical Industries Ltd Stock including INR - Dollar returns
The Teva Pharmaceutical Industries Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Teva Pharmaceutical Industries Ltd investment value today
Current value as on today
₹1,57,809
Returns
₹57,809
(+57.81%)
Returns from Teva Pharmaceutical Industries Ltd Stock
₹51,835 (+51.83%)
Dollar Returns*
₹5,974 (+5.97%)
Analyst Recommendation on Teva Pharmaceutical Industries Ltd Stock
Based on 9 analysts
0.00%
Buy
33.33%
Hold
66.67%
Sell
Based on 9 analysts, 66.67% of analysts recommend a 'SELL' rating for Teva Pharmaceutical Industries Ltd. Average target price of $35.32
Teva Pharmaceutical Industries Ltd Share Price Target
Get share price movements and forecasts by analysts on Teva Pharmaceutical Industries Ltd.
What analysts predicted
7.45%UPSIDE
Target Price
$35.32
Current Price
$32.69
Analyzed by
9 Analysts
Target
$35.32
Teva Pharmaceutical Industries Ltd target price $35.32, a slight upside of 7.45% compared to current price of $32.69. According to 9 analysts rating.
Teva Pharmaceutical Industries Ltd Stock’s Investor Sentiment and Interest
Search interest for Teva Pharmaceutical Industries Ltd Stock has increased by 33% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:33% versus previous 30 day period
Teva Pharmaceutical Industries Ltd Quarterly Profit & Loss
All numbers in Millions USD
Teva Pharmaceutical Industries Ltd Annual Profit & Loss
All numbers in Millions USD
Teva Pharmaceutical Industries Ltd Quarterly Cash Flow
All numbers in Millions USD
Teva Pharmaceutical Industries Ltd Annual Cash Flow
All numbers in Millions USD
Teva Pharmaceutical Industries Ltd News & Key Events
Today's Timeline - 12 January
Mon, 10:56 PM
-Teva and Royalty Pharma announce $500 million funding for TEV-408's clinical development in vitiligo and celiac disease.
Insights on Teva Pharmaceutical Industries Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Teva Pharmaceutical Industries Ltd has shown positive revenue growth over the last three quarters. Their revenue has increased from $3.89 billion to $4.48 billion, with an average increase of 6.8% each quarter.
- POSITIVE IMPACT
Profit Spike
Teva Pharmaceutical Industries Ltd has shown a positive trend in its net profit over the last 6 quarters, increasing from a loss of $846.0 million to a profit of $433.0 million. This marks an average increase of 91.1% in net profit each quarter, indicating strong improvement in financial performance.
- POSITIVE IMPACT
Price Rise
In the last 3 months, TEVA stock has moved up by 64.5%
NO EFFECTAgainst Peers
In the last 1 year, Regencell Bioscience Holdings Ltd has given 28567.3% return, outperforming this stock by 28516.2%
- NO EFFECT
Against Peers
In the last 3 years, Regencell Bioscience Holdings Ltd has given 3962.6% return, outperforming this stock by 3749.2%
About Teva Pharmaceutical Industries Ltd
| Organisation | Teva Pharmaceutical Industries Ltd |
| Headquarters | 124 Dvora HaNevi?a St., Tel Aviv-Yafo, Israel, 6944020 |
| Industry | Health Technology |
| CEO | Mr. Richard D. Francis |
| E-voting on shares | Click here to vote |
Key Management of Teva Pharmaceutical Industries Ltd
Name | Title |
|---|---|
Mr. Eliyahu Sharon Kalif | Executive VP & CFO |
Mr. Amir Weiss | Senior VP & Chief Accounting Officer |
Kathleen Veit | Senior Vice President, Global Compliance & Ethics Officer |
Mr. Richard D. Francis | President, CEO & Director |
Mr. Richard Gordon Daniell | Executive Vice President of European Commercial |
Dr. Eric A. Hughes M.D., Ph.D. | Executive VP of Global R&D and Chief Medical Officer |
Ms. Christine Fox | Executive VP of US Commercial & Head of Innovative Franchise |
Mr. Matthew Shields | Executive Vice President of Global Operations |
Mr. Christopher J. Stevo CFA | Senior Vice President of Investor Relations & Competitive Intelligence |
Mr. David R. Mcavoy J.D. | Executive VP & Chief Legal Officer |
FAQs
What is Teva Pharmaceutical Industries Ltd share price today?
Teva Pharmaceutical Industries Ltd share price today is $32.69 as on . Teva Pharmaceutical Industries Ltd share today touched a day high of $32.83 and a low of $30.98.
What is the 52 week high and 52 week low for Teva Pharmaceutical Industries Ltd share?
Teva Pharmaceutical Industries Ltd share touched a 52 week high of $33.42 on and a 52 week low of $12.47 on . Teva Pharmaceutical Industries Ltd stock price today i.e. is trending at $32.69,which is 2.18% down from its 52 week high and 162.25% up from its 52 week low.
What is Teva Pharmaceutical Industries Ltd's market capitalisation today?
Teva Pharmaceutical Industries Ltd market capitalisation is $0.04T as on .
How to invest in Teva Pharmaceutical Industries Ltd Stock (TEVA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Teva Pharmaceutical Industries Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Teva Pharmaceutical Industries Ltd Shares that will get you 0.0459 shares as per Teva Pharmaceutical Industries Ltd share price of $32.69 per share as on January 28, 2026 at 9:39 pm IST.
What is the minimum amount required to buy Teva Pharmaceutical Industries Ltd Stock (TEVA) from India?
Indian investors can start investing in Teva Pharmaceutical Industries Ltd (TEVA) shares with as little as ₹91.762 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in Teva Pharmaceutical Industries Ltd stock (as per the Rupee-Dollar exchange rate as on ).
Based on Teva Pharmaceutical Industries Ltd share’s latest price of $32.69 as on January 28, 2026 at 9:39 pm IST, you will get 0.3059 shares of Teva Pharmaceutical Industries Ltd. Learn more about
fractional shares .
What are the returns that Teva Pharmaceutical Industries Ltd has given to Indian investors in the last 5 years?
Teva Pharmaceutical Industries Ltd stock has given 165.55% share price returns and 25.73% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?